{"version":"1.0","type":"link","title":"Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparison.","author_name":"Bauer T 외","author_url":"https://prs-insight.online/author/Bauer%20T","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/99322","thumbnail_width":1200,"thumbnail_height":630}